Journal
CANCER TREATMENT REVIEWS
Volume 41, Issue 7, Pages 646-652Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.ctrv.2015.05.011
Keywords
TKI; Mucositis; Diarrhoea; Chloride secretion; ErbB (EGFR, HER)
Categories
Ask authors/readers for more resources
Diarrhoea is a common, debilitating and potentially life threatening toxicity of many cancer therapies. While the mechanisms of diarrhoea induced by traditional chemotherapy have been the focus of much research, the mechanism(s) of diarrhoea induced by small molecule ErbB TKI, have received relatively little attention. Given the increasing use of small molecule ErbB TKIs, identifying this mechanism is key to optimal cancer care. This paper critically reviews the literature and forms a hypothesis that diarrhoea induced by small molecule ErbB TKIs is driven by intestinal chloride secretion based on the negative regulation of chloride secretion by ErbB receptors being disrupted by tyrosine kinase inhibition. (C) 2015 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available